News

Adam Greenbaum, MD, presents late-breaking data at ACC.26.

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel

A new embolic protection device from Emboline was noninferior to the FDA-approved Sentinel device in terms of safety and efficacy. In addition, it captured much more TAVR-generated debris and was linked to an improved technical success rate.

AI model algorithm tablet digital patient data

FDA clears new AI model for pulmonary hypertension

The advanced algorithm, which previously received the FDA's breakthrough device designation, detects signs of pulmonary hypertension in standard 12-lead electrocardiograms.

artificial intelligence AI predictive analytics

UCLA's first dean for health AI strategy and innovation takes office

“The creation of an associate dean in AI speaks to the fact that AI has become central to research, education and clinical operations in the health care system."

Statue of Liberty New York City healthcare

DOJ accuses New York health system of engaging in anticompetitive business practices

In a complaint filed in federal court, the U.S. Department of Justice claims NewYork-Presbyterian Hospital uses its power of “scale, breadth and configuration” to control payer contracts, making it difficult for insurers to develop low-cost plans. The health system denies any wrongdoing.

Medical malpractice gavel diagnostic error mistake stethoscope

Patient injected with acid instead of saline earns undisclosed settlement

The disturbing case highlights a series of process errors and cost-cutting measures that ultimately led to the “never event” accident.

‘Practice-changing’ interventional cardiology research grabs ACC.26 spotlight

The second day of the American College of Cardiology’s annual conference started with a series of highly anticipated interventional cardiology trials.

Stavros V. Konstantinides, MD, PhD, presenting data at ACC.26

Catheter-based treatment linked to major benefits for intermediate-risk PE

New 30-day data presented at ACC.26 helped answer questions cardiologists have had been asking for years. “Thank you for bringing PE into the future," one vascular specialist said from the stage.

FDA sees promise in voice-based AI model for heart failure

An advanced algorithm that looks for signs of heart failure in five-second voice recordings has received the FDA's breakthrough device designation.

stroke brain dementia alzheimer's puzzle mental health

AI-based ARIA detection software could bring 'renewed hope' for people undergoing Alzheimer's treatment

The software is the first of its kind to achieve the FDA's approval for detecting, measuring and grading ARIA on MRI scans—a task that is critical in managing the disease.

doctor with overweight patient who may be treated with TAVR or surgery

Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years

The popular diabetes drug, which can also benefit patients with heart failure and sleep apnea, resulted in an average weight loss of 23%. Once treatment stopped, the effects started to fade rather quickly.

SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA

The Society of Cardiovascular Computed Tomography is cheering as a “huge win” the 2025 CMS payment increase for coronary CTA that more than doubles the current payment and “better aligns with the cost of providing CCTA services." The panel expects the move to bring an increase in CT utilization, more adoption with financial sustainability and greater access in currently underutilized areas.

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Working with Medicare Advantage insurance plans is like playing poker in the Wild West. And it’s gotten a lot harder to win since the cowboys started using AI.

Around the web

Cardiovascular Business

New stroke prevention device for TAVR holds its own in head-to-head battle with Sentinel